A

Ardelyx
D

ARDX

5.05500
USD
-0.65
(-11.39%)
مغلق
حجم التداول
285,329
الربح لكل سهم
-0
العائد الربحي
-
P/E
-16
حجم السوق
1,197,298,335
أصول ذات صلة
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    B
    BPMC
    -2.080
    (-2.20%)
    92.280 USD
    C
    CRBP
    -0.09000
    (-1.09%)
    8.20000 USD
    D
    DVAX
    0.000
    (0.00%)
    13.335 USD
    G
    GLMD
    0.16000
    (6.25%)
    2.72000 USD
    V
    VKTX
    2.480
    (7.85%)
    34.090 USD
    المزيد
الأخبار المقالات

العنوان: Ardelyx

القطاع: Healthcare
الصناعة: Biotechnology
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.